2017-03-06,Howard Mayer, M.D., Of Shire, Joins Genocea Biosciences' Board Of Directors
2017-03-01,Genocea To Present At The Cowen And Company 37th Annual Health Care Conference
2017-02-16,Genocea Reports Fourth Quarter And Year-End 2016 Financial Results
2017-02-09,Genocea To Host Fourth Quarter And Year End 2016 Financial Results Conference Call & Webcast On February 16, 2017
2017-01-05,Genocea Announces Positive 6-Month Results From GEN-003 Phase 2b Clinical Trial
2016-12-14,Genocea R&D Day Highlighted Lead Program, GEN-003, For The Treatment Of Genital Herpes And Introduced Immuno-Oncology Programs & Strategy
2016-12-14,Genocea Announces Research Collaboration With Checkmate Pharmaceuticals In Advanced Melanoma
2016-12-08,Genocea To Host Virtual R&D Day On December 14th, 2016
2016-11-11,Genocea's Proprietary ATLAS™ Technology Identifies Unique Candidate Antigens For Potential Personalized Cancer Vaccines
2016-11-09,Genocea To Present At Two Upcoming November Conferences
2016-11-03,Genocea Reports Third Quarter 2016 Financial Results
2016-10-28,Genocea Presents New 12 Month Data On Genital Herpes Immunotherapy GEN-003 At IDWeek 2016
2016-10-27,Genocea To Host Third Quarter 2016 Financial Results Conference Call & Webcast On November 3, 2016
2016-10-06,RSI Alert: Genocea Biosciences (GNCA) Now Oversold
2016-09-29,Genocea's Genital Herpes Immunotherapy GEN-003 Demonstrates Significant Reduction Of Viral Shedding In Phase 2b Clinical Trial
2016-08-09,Genocea Congratulates Jessica Baker Flechtner, Ph.D. For Recognition On 2016's 40 Women To Watch Over 40 List
2016-08-04,Genocea Reports Second Quarter 2016 Financial Results
2016-07-28,Genocea To Host Second Quarter 2016 Financial Results Conference Call & Webcast On August 4, 2016
2016-07-06,Genocea To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference
2016-06-29,Genocea Biosciences (GNCA) Highlighted As Weak On High Volume
2016-06-29,7 Stocks Under $10 Making Big Moves
2016-06-09,Genocea Appoints Ron Cooper To Board Of Directors
2016-06-09,Genocea Showcases Potential Of Genital Herpes Immunotherapy GEN-003 At ASM Microbe 2016
2016-05-31,6 Breakout Stocks Under $10 Set to Soar
2016-05-23,Genocea Appoints Dr. John E. Bishop As Senior Vice President Of Pharmaceutical Sciences
2016-05-17,Genocea To Present At The 2016 UBS Global Healthcare Conference
2016-05-05,Genocea Reports First Quarter 2016 Financial Results
2016-04-28,Genocea To Host First Quarter 2016 Financial Results Conference Call & Webcast On May 5, 2016
2016-04-20,Genocea Congratulates Dr. George Siber, 2016 Albert B. Sabin Gold Medal Award Recipient
2016-04-12,Today's Dead Cat Bounce Stock: Genocea Biosciences (GNCA)
2016-04-11,Genocea Biosciences (GNCA) Highlighted As Weak On High Volume
2016-04-06,Genocea To Present At The 15th Annual Needham Healthcare Conference
2016-04-05,Strong On High Relative Volume: Genocea Biosciences (GNCA)
2016-04-04,Trade-Ideas: Genocea Biosciences (GNCA) Is Today's "Dead Cat Bounce" Stock
2016-04-01,Genocea Biosciences (GNCA) In A Perilous Reversal
2016-03-31,Genocea Biosciences (GNCA) Stock Soars on Positive Trial Results
2016-03-31,Genital Herpes Immunotherapy GEN-003 Shows Sustained Reduction Of Viral Shedding Rate, Durable Impact On Clinical Disease 12 Months Post-Dosing
2016-03-10,5 Stocks Under $10 Set to Soar Higher
2016-02-29,Genocea To Present At The Cowen And Company 36th Annual Health Care Conference
2016-02-26,Short Interest In Genocea Biosciences Moves 31.7% Higher
2016-02-12,5 Breakout Stocks to Trade for Big Gains
2016-02-11,Genocea Reports Fourth Quarter And Year-End 2015 Financial Results
2016-02-04,Genocea To Host Fourth Quarter And Year End 2015 Financial Results Conference Call & Webcast On February 11, 2016
2016-02-01,Genocea To Present At 2016 BIO CEO & Investor Conference
2016-01-29,Genocea Commences Dosing In Phase 2b Study For Genital Herpes Treatment, GEN-003
2016-01-22,8 Stocks Under $10 Making Big Moves Higher
2016-01-06,Genocea Biosciences Becomes Oversold (GNCA)
2015-12-17,Insider Trading Alert - GNCA, DXCM And SCOR Traded By Insiders
2015-11-24,Genocea To Present At The Piper Jaffray 27th Annual Healthcare Conference
2015-11-11,Genocea To Present At The Stifel 2015 Healthcare Conference
2015-11-05,Genocea Reports Third Quarter 2015 Financial Results
2015-11-05,Genocea Announces Immuno-Oncology Research Collaboration With Memorial Sloan Kettering Cancer Center
2015-11-04,Genocea Presents Positive Findings From ATLASTM Immuno-Oncology Research Collaboration At 2015 SITC Annual Meeting
2015-10-29,5 Stocks Under $10 Set to Soar Higher
2015-10-29,Genocea To Host Third Quarter 2015 Financial Results Conference Call & Webcast On November 5, 2015
2015-10-27,Genocea Announces Publications Highlighting ATLAS™ T Cell Antigen Discovery Efforts In Chlamydia And Malaria
2015-10-19,Relative Strength Alert For Genocea Biosciences
2015-10-19,Genocea Announces Top-Line Results From Phase 2a Trial For Universal Pneumococcal Vaccine Candidate GEN-004
2015-10-14,Genocea Biosciences (GNCA): Today's Weak On High Volume Stock
2015-10-13,Genocea Biosciences (GNCA) Flagged As Strong On High Volume
2015-10-07,Genocea Announces Positive Durability Data From 6-Month Analysis Of Phase 2 Clinical Trial Of Genital Herpes Immunotherapy GEN-003
2015-08-06,Genocea Reports Second Quarter 2015 Financial Results
2015-08-04,Genocea Biosciences, Inc. Announces Closing Of $50 Million Public Offering Of Common Stock
2015-07-30,Genocea To Host Second Quarter 2015 Financial Results Conference Call & Webcast On August 6, 2015
2015-07-30,Genocea Biosciences, Inc. Announces Pricing Of $50 Million Public Offering
2015-07-29,Genocea Biosciences, Inc. Commences Public Offering Of Common Stock
2015-05-20,Genocea Announces Positive Top-Line Phase 2 Data For Genital Herpes Immunotherapy GEN-003
2015-05-13,Genocea To Present At The UBS Global Healthcare Conference
2015-05-07,Genocea Biosciences is Now Oversold (GNCA)
2015-05-07,Genocea Reports First Quarter 2015 Financial Results
2015-04-30,Genocea To Host First Quarter 2015 Financial Results Conference Call & Webcast On May 7, 2015
2015-04-22,Genocea Completes Enrollment In Phase 2a Human Challenge Study Of GEN-004 For The Prevention Of Infection By Pneumococcus
2015-04-08,Genocea To Present At The 14th Annual Needham & Co. Healthcare Conference
2015-03-17,Genocea Biosciences, Inc. Announces Closing Of $51.7 Million Public Offering Of Common Stock And Exercise In Full Of Underwriters' Option To Purchase Additional Shares
2015-03-12,3 Health Care Stocks Under $10 to Trade for Breakouts
2015-03-12,Genocea Biosciences, Inc. Announces Pricing Of $45 Million Public Offering
2015-03-11,Genocea Biosciences, Inc. Commences Public Offering Of Common Stock
2015-03-06,Ratings Changes Today
2015-02-27,Genocea Appoints Michael Higgins To Its Board Of Directors
2015-02-25,Genocea To Present At The Cowen And Company 35th Annual Health Care Conference
2015-02-12,Genocea Reports Fourth Quarter And Year-End 2014 Financial Results
2015-02-05,Genocea To Host Fourth Quarter And Year End 2014 Financial Results Conference Call & Webcast On February 12, 2015
2015-02-02,Genocea To Present At The 2015 BIO CEO & Investor Conference
2015-01-29,5 Under-$10 Health Care Stocks Setting Up to Trade Higher
2015-01-21,RSI Alert: Genocea Biosciences (GNCA) Now Oversold
2015-01-07,Genocea Completes Enrollment Early In Phase 2 Dose Optimization Trial Of GEN-003 For Treatment Of Genital Herpes
2014-12-15,Genocea Appoints Eric S. Hoffman As Chief Business Officer
2014-11-25,Genocea To Present At Upcoming Investor Conferences
2014-11-21,Genocea Secures Debt Facility From Hercules Technology Growth Capital Of Up To $27 Million
2014-11-13,Genocea Named In Top Places To Work List By The Boston Globe
2014-11-12,Genocea To Present At The Stifel Nicolaus 2014 Healthcare Conference
2014-11-06,Genocea Reports Third Quarter 2014 Financial Results
2014-11-05,Genocea Profiles T Cell Responses To Identify Antigens Associated With Malaria Episodes
2014-10-30,Genocea To Announce Third Quarter 2014 Financial Results On November 6, 2014
2014-10-08,Genocea Presents Complete Phase 1/2a Data For HSV-2 Immunotherapy At IDWeek
2014-09-23,Genocea Announces $1.2 Million Grant For Malaria Vaccine Discovery
2014-09-22,Genocea Biosciences Becomes Oversold (GNCA)
2014-09-19,Genocea To Present At The 21st Annual NewsMakers In The Biotech Industry Conference
2014-09-16,Virology Publishes Genocea HSV-2 Antigen Discovery Paper
2014-09-11,Genocea Commences Phase 2a Trial For GEN-004, Universal Pneumococcal Vaccine Candidate
2014-09-11,Genocea Appoints Kenneth Bate To Its Board Of Directors
2014-09-06,Genocea Presents Phase 1 Immunology Data For Novel Pneumoccocus Vaccine At ICAAC
2014-08-06,Genocea Reports Second Quarter 2014 Financial Results
2014-07-30,Genocea To Announce Second Quarter 2014 Financial Results On August 6, 2014
2014-07-22,Genocea HSV-2 Immunotherapeutic GEN-003 Elicits Significant, Durable T Cell Responses In Vaccinated Subjects
2014-07-21,Genocea Commences Phase 2 Dose Optimization Trial For GEN-003 HSV-2 Immunotherapy
2014-07-16,Genocea Biosciences, Inc. Elects Not To Pursue Public Offering
2014-07-14,Genocea Biosciences, Inc. Commences Public Offering Of Common Stock
2014-06-23,4 Stocks Breaking Out on Big Volume
2014-04-01,3 Biotech Stocks Rising on Unusual Volume
2014-02-12,Top Insider Trades: EPZM IDTI GAIN GNCA
,
,
